Global /Canada /Healthcare /Medical Care Facilities /IOT
chevron_leftBack
Innovotech Inc. logo

Innovotech Inc.

IOT
TSXV: IOT Delayed
0.2200CAD 6%
0.1577 USD
As of 6 June 2026, Innovotech Inc. has a market cap of $8.1M USD, ranking #42361 globally and #1752 in Canada. It ranks #3747 in the Healthcare sector, and #449 in the Medical Care Facilities industry.
Global Rank
42361
Country Rank
1752
Sector Rank
3747
Industry Rank
449
Key Stats
Market Cap
$8.1MUSD
11.3M CAD
Enterprise Value
$7.09MUSD
9.89M CAD
Revenue (TTM)
$3.25MUSD
4.53M CAD
EBITDA (TTM)
$119.56KUSD
166.78K CAD
Net Income (TTM)
$67.65KUSD
94.38K CAD
EBITDA Margin
3.7%
Profit Margin
2.1%
PE Ratio
111.6
PS Ratio
2.5
PB Ratio
3.1
EV/EBITDA
59.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Craig Milne open_in_new
Employees
16
Website
innovotech.ca open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
6% 16% 38% -17% -10% 52%

News

Loading...

Markets

Exchange Ticker Price
TSX Venture Exchange
MIC: XTSX
PRIMARY
IOT
Innovotech Inc
ISIN: CA45772U1049
Shares Out.:
54.438M1 Shares Float: 32.28M2
TV:
SA:
YF:
GF:
BA:
IOT
MS:
0.2200 CAD
Cboe Canada
MIC: NEOE
IOT
Innovotech Inc
ISIN: CA45772U1049
TV:
SA:
YF:
GF:
BA:
IOT
MS:
0.1200 CAD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Innovotech Inc.

Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assay lids; and order biofilm assays. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices testing; bacteriophage testing; and analytical services. The company serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food. Innovotech Inc. is headquartered in Edmonton, Canada.

Similar Companies

Industry: Medical Care Facilities (Canada)
Name
Market Cap diff.
PE
EXE
$2.04B
2.85B CAD
25K%
27.1
$1.77B
2.47B CAD
22K%
48.0
$1.58B
2.2B CAD
19K%
-
$770.99M
1.08B CAD
9K%
-
$215.77M
300.99M CAD
3K%
21.3
AIDX
$195.19M
272.27M CAD
2K%
-
Industry: Medical Care Facilities (Global)
Name
Market Cap diff.
PE
$232.18B
852.82B AED
3M%
44.1
$96.73B
1M%
14.9
$26.68B
22.97B EUR
329K%
15.0
$25.58B
22.02B EUR
316K%
24.9
$22.48B
84.42B SAR
278K%
35.2
$21.13B
261K%
24.6
chevron_leftBack